Progressive Hits 5-week Low

Trading Economics00:53

Express News | NYSE Order Imbalance 61666.0 Shares on Buy Side

BreakingsMay 23 03:50

Transposon Receives US FDA Fast Track Designation for TPN-101 for Progressive Supranuclear Palsy

Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative ...

PR NewswireMay 21 19:00

Progressive Ranked 'Top Pick' by Morgan Stanley on Growth, Valuation

Progressive (PGR) has been ranked a "top pick" by Morgan Stanley, citing strong growth prospects and attractive pricing, while also noting that growth and margin remain "underappreciated". "The stock

MT NewswiresMay 21 00:56

Progressive Is Maintained at Overweight by Wells Fargo

Progressive Is Maintained at Overweight by Wells Fargo

Dow JonesMay 21 00:01

Wells Fargo Maintains Overweight on Progressive, Lowers Price Target to $243

Wells Fargo analyst Elyse Greenspan maintains Progressive with a Overweight and lowers the price target from $244 to $243.

Analyst UpgradesMay 20 23:52